Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 17/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 17/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 17/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 17/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 17/20 | 0.52 |
| ▸ | HDAC10 | Q969S8 | 16/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 16/20 | 0.52 |
| ▸ | HDAC5 | Q9UQL6 | 14/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 13/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 13/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 13/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23520806 | 0.82 | HDAC3 (0.53) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL4536707 | 0.80 | HDAC8 (0.75) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL4530630 | 0.80 | HDAC8 (0.75) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL4533409 | 0.80 | HDAC8 (0.75) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL4528411 | 0.80 | HDAC8 (0.75) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL4533728 | 0.80 | HDAC8 (0.75) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL4529056 | 0.80 | HDAC8 (0.75) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL4531336 | 0.80 | HDAC8 (0.75) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL4535833 | 0.80 | HDAC8 (0.75) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL4520257 | 0.80 | HDAC8 (0.75) | HDAC3HDAC1HDAC2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4162955-A1 | CNP PRODRUGS WITH CARRIER ATTACHMENT AT THE RING MOIETY | Ascendis Pharma Growth Disorders A/S (DK) | 2023-04-12 | — | — | EP | disclosed |
| WO-2017118707-A1 | CONTROLLED-RELEASE CNP AGONISTS WITH REDUCED SIDE-EFFECTS | ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) | 2017-07-13 | — | — | WO | disclosed |
| WO-2017118704-A1 | CONTROLLED-RELEASE CNP AGONISTS WITH LOW NPR-C BINDING | ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) | 2017-07-13 | — | — | WO | disclosed |
| WO-2017118703-A1 | CONTROLLED-RELEASE CNP AGONISTS WITH LOW INITIAL NPR-B ACTIVITY | ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) | 2017-07-13 | — | — | WO | disclosed |
| WO-2017118700-A1 | CONTROLLED-RELEASE CNP AGONISTS WITH INCREASED NEP STABILITY | ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) | 2017-07-13 | — | — | WO | disclosed |